• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HIN
Click for more information
0.00% $2.37

HEARTWARE INTERNATIONAL, INC - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
HINChange of Director's Interest Notice03/09/12
HINOptions Exercise - ASX Appendix 3B03/09/12
HINChange of Director's Interest Notice28/08/12
HINASX Appendix 3B - Options Exercise24/08/12
HINChange of Director's Interest Notice22/08/12
HINHeartWare to Webcast Presentation at Canaccord Genuity Growt10/08/12
HINHeartWare to Webcast Presentation at Wedbush PacGrow Lifesci10/08/12
HINAppendix 4D and Half Year Financial StatementPRICE SENSITIVE09/08/12
HINASX Appendix 3B - Consideration for World Heart Acquisition08/08/12
HINReports 2012 Q2 Rev of US$29.1 M vs US$20.4 M in 2011 Q2PRICE SENSITIVE08/08/12
HINChange of Director's Interest Notice07/08/12
HINASX Appendix 3B - Options Exercise07/08/12
HINHeartWare Completes Acquisition of World Heart CorpPRICE SENSITIVE03/08/12
HINNotice of Second Quarter Financial Results Call31/07/12
HINOption Exercise - ASX Appendix 3B20/07/12
HINChange of Director's Interest Notice19/07/12
HINChange of Director's Interest Notice18/07/12
HINHeartWare Names Peter McAree Chief Financial Officer10/07/12
HINChange of Director's Interest Notice06/07/12
HINASX Appendix 3B - Options Exercise and Forfeiture06/07/12
HINChange of Director's Interest Notice06/07/12
HINASX Appendix 3B - Options Exercise27/06/12
HINChange of Director's Interest Notice20/06/12
HINOption Exercise - ASX Appendix 3B19/06/12
HINChange of Director's Interest Notice15/06/12
HINASX Appendix 3B - Options Exercise15/06/12
HINHeartWare Names New Company Secretary14/06/12
HINGrant of Incentive Equity - ASX Appendix 3B13/06/12
HINChange of Director's Interest Notice12/06/12
HINASX Appendix 3B - Options Exercise and Forfeiture07/06/12
HINChange of Director's Interest x 806/06/12
HINASX Appendix 3Z - Final Director's Interest Notice06/06/12
HINAnnual General Meeting Results01/06/12
HINAnnual General Meeting Materials01/06/12
HINChange of Director's Interest Notice29/05/12
HINASX Appendix 3B - Options Exercise, Vesting and Cancellation25/05/12
HINHeartWare Announces Publication of Data from U.S. Bridge toPRICE SENSITIVE24/05/12
HINHeartWare Receives CE Mark Addendum For Label ExpansionPRICE SENSITIVE24/05/12
HINChange of Director's Interest Notice23/05/12
HINChange of Director's Interest Notice22/05/12
HINChange of Director's Interest22/05/12
HINChange of Director's Interest Notice22/05/12
HINChange of Director's Interest Notice15/05/12
HINChange of Director's Interest x 715/05/12
HINReports 2012 Q1 Rev of US$26.3 M vs US$18.0M in Q1 of 2011PRICE SENSITIVE11/05/12
HINHeartWare Completes Enrollment in Destination Therapy StudyPRICE SENSITIVE09/05/12
HINHeartWare to Webcast Presentation at Bank of America Health08/05/12
HINNotice of First Quarter Financial Results Call04/05/12
HINOption Exercise - ASX Appendix 3B01/05/12
HINChange of Director's Interest Notice01/05/12
HINChange of Director's Interest Notice01/05/12
HINNotice of Annual General Meeting30/04/12
HINHeartWare Receives Favorable US FDA Panel VotePRICE SENSITIVE26/04/12
HINASX Appendix 3B - Options Vesting, Exercise and Cancellation03/04/12
HINHeartWare Enters Agreement to Acquire WorldHeart for US$8MPRICE SENSITIVE30/03/12
HINASX Appendix 3B - Options Grant and Cancellation26/03/12
HINASX Appendix 3B - Options vesting, exercise and cancellation19/03/12
HINHeartWare Receives New CAP Allotment from FDA for Bridge toPRICE SENSITIVE19/03/12
HINChange of Director's Interest Notice14/03/12
HINChange of Director's Interest Notice07/03/12
HINHeartWare to Webcast Presentation at Barclays Global Healthc07/03/12
HINInitial Director's Interest Notice06/03/12
HINChange of Director's Interest Notice02/03/12
HINChange of Director's Interest Notice02/03/12
HINAnnual Report for 2011 and ASX Appendix 4EPRICE SENSITIVE28/02/12
HINChange of Director's Interest Notice27/02/12
HINChange of Director's Interest Notice20/02/12
HINReports Q4 Rev of US$23.1M and Annual 2011 Rev of US$82.8MPRICE SENSITIVE17/02/12
HINHeartWare Announces Date for FDA Advisory Committee PanelPRICE SENSITIVE15/02/12
HINNotice of Fourth Quarter Financial Results Call07/02/12
HINChange of Director's Interest Notice02/02/12
HINQ4 2011 Preliminary Revenue and JPM ConferencePRICE SENSITIVE10/01/12
HINHeartWare and Dualis Announce Development AgreementPRICE SENSITIVE10/01/12
HINChange of Director's Interest Notice09/01/12
HINHeartWare to Webcast Presentation at JP Morgan Healthcare Co05/01/12
HINGrant of Incentive Equity - ASX Appendix 3B28/12/11
HINChange of Director's Interest Notice28/12/11
HINASX Appendix 3B - Options Exercise28/12/11
HINOption Exercise - ASX Appendix 3B15/12/11
HINChange of Director's Interest Notice15/12/11
HINHeartWare to Present at Oppenheimer Healthcare Conference12/12/11
HINChange of Director's Interest Notice06/12/11
HINAppendix 3B - Options Exercise06/12/11
HINAmended Change of Director's Interest Notice05/12/11
HINASX Appendix 3B - Options Exercise25/11/11
HINHeartWare to Present at Piper Jaffray Health Care Conference24/11/11
HINChange of Director's Interest Notice18/11/11
HINASX Appendix 3B - Options Exercise14/11/11
HINHeartWare to Present at Lazard Capital Markets Healthcare Co11/11/11
HINThird Quarter 2011 Financial ResultsPRICE SENSITIVE04/11/11
HINHeartWare Announces Third Quarter Revenues of US$21.3 MPRICE SENSITIVE28/10/11
HINHeartWare Announces Planned Departure of CFOPRICE SENSITIVE28/10/11
HINNotice of Third Quarter Financial Results Call24/10/11
HINGrant of Incentive Equity - ASX Appendix 3B20/10/11
HINChange of Director's Interest Notice10/10/11
HINPresentation of Clinical Update for BTT and CAP at EACTS03/10/11
HINHeartWare Announces Updated Clinical Data Presented at EACTSPRICE SENSITIVE03/10/11
HINHeartWare to Present Clinical Update at 25th EACTS in Lisbon29/09/11
HINASX Appendix 3B - Options Exercise and Vesting22/09/11
HINChange of Director's Interest Notice21/09/11
HINChange of Director's Interest Notice
03/09/12
HINOptions Exercise - ASX Appendix 3B
03/09/12
HINChange of Director's Interest Notice
28/08/12
HINASX Appendix 3B - Options Exercise
24/08/12
HINChange of Director's Interest Notice
22/08/12
HINHeartWare to Webcast Presentation at Canaccord Genuity Growt
10/08/12
HINHeartWare to Webcast Presentation at Wedbush PacGrow Lifesci
10/08/12
HINAppendix 4D and Half Year Financial Statement
09/08/12PRICE SENSITIVE
HINASX Appendix 3B - Consideration for World Heart Acquisition
08/08/12
HINReports 2012 Q2 Rev of US$29.1 M vs US$20.4 M in 2011 Q2
08/08/12PRICE SENSITIVE
HINChange of Director's Interest Notice
07/08/12
HINASX Appendix 3B - Options Exercise
07/08/12
HINHeartWare Completes Acquisition of World Heart Corp
03/08/12PRICE SENSITIVE
HINNotice of Second Quarter Financial Results Call
31/07/12
HINOption Exercise - ASX Appendix 3B
20/07/12
HINChange of Director's Interest Notice
19/07/12
HINChange of Director's Interest Notice
18/07/12
HINHeartWare Names Peter McAree Chief Financial Officer
10/07/12
HINChange of Director's Interest Notice
06/07/12
HINASX Appendix 3B - Options Exercise and Forfeiture
06/07/12
HINChange of Director's Interest Notice
06/07/12
HINASX Appendix 3B - Options Exercise
27/06/12
HINChange of Director's Interest Notice
20/06/12
HINOption Exercise - ASX Appendix 3B
19/06/12
HINChange of Director's Interest Notice
15/06/12
HINASX Appendix 3B - Options Exercise
15/06/12
HINHeartWare Names New Company Secretary
14/06/12
HINGrant of Incentive Equity - ASX Appendix 3B
13/06/12
HINChange of Director's Interest Notice
12/06/12
HINASX Appendix 3B - Options Exercise and Forfeiture
07/06/12
HINChange of Director's Interest x 8
06/06/12
HINASX Appendix 3Z - Final Director's Interest Notice
06/06/12
HINAnnual General Meeting Results
01/06/12
HINAnnual General Meeting Materials
01/06/12
HINChange of Director's Interest Notice
29/05/12
HINASX Appendix 3B - Options Exercise, Vesting and Cancellation
25/05/12
HINHeartWare Announces Publication of Data from U.S. Bridge to
24/05/12PRICE SENSITIVE
HINHeartWare Receives CE Mark Addendum For Label Expansion
24/05/12PRICE SENSITIVE
HINChange of Director's Interest Notice
23/05/12
HINChange of Director's Interest Notice
22/05/12
HINChange of Director's Interest
22/05/12
HINChange of Director's Interest Notice
22/05/12
HINChange of Director's Interest Notice
15/05/12
HINChange of Director's Interest x 7
15/05/12
HINReports 2012 Q1 Rev of US$26.3 M vs US$18.0M in Q1 of 2011
11/05/12PRICE SENSITIVE
HINHeartWare Completes Enrollment in Destination Therapy Study
09/05/12PRICE SENSITIVE
HINHeartWare to Webcast Presentation at Bank of America Health
08/05/12
HINNotice of First Quarter Financial Results Call
04/05/12
HINOption Exercise - ASX Appendix 3B
01/05/12
HINChange of Director's Interest Notice
01/05/12
HINChange of Director's Interest Notice
01/05/12
HINNotice of Annual General Meeting
30/04/12
HINHeartWare Receives Favorable US FDA Panel Vote
26/04/12PRICE SENSITIVE
HINASX Appendix 3B - Options Vesting, Exercise and Cancellation
03/04/12
HINHeartWare Enters Agreement to Acquire WorldHeart for US$8M
30/03/12PRICE SENSITIVE
HINASX Appendix 3B - Options Grant and Cancellation
26/03/12
HINASX Appendix 3B - Options vesting, exercise and cancellation
19/03/12
HINHeartWare Receives New CAP Allotment from FDA for Bridge to
19/03/12PRICE SENSITIVE
HINChange of Director's Interest Notice
14/03/12
HINChange of Director's Interest Notice
07/03/12
HINHeartWare to Webcast Presentation at Barclays Global Healthc
07/03/12
HINInitial Director's Interest Notice
06/03/12
HINChange of Director's Interest Notice
02/03/12
HINChange of Director's Interest Notice
02/03/12
HINAnnual Report for 2011 and ASX Appendix 4E
28/02/12PRICE SENSITIVE
HINChange of Director's Interest Notice
27/02/12
HINChange of Director's Interest Notice
20/02/12
HINReports Q4 Rev of US$23.1M and Annual 2011 Rev of US$82.8M
17/02/12PRICE SENSITIVE
HINHeartWare Announces Date for FDA Advisory Committee Panel
15/02/12PRICE SENSITIVE
HINNotice of Fourth Quarter Financial Results Call
07/02/12
HINChange of Director's Interest Notice
02/02/12
HINQ4 2011 Preliminary Revenue and JPM Conference
10/01/12PRICE SENSITIVE
HINHeartWare and Dualis Announce Development Agreement
10/01/12PRICE SENSITIVE
HINChange of Director's Interest Notice
09/01/12
HINHeartWare to Webcast Presentation at JP Morgan Healthcare Co
05/01/12
HINGrant of Incentive Equity - ASX Appendix 3B
28/12/11
HINChange of Director's Interest Notice
28/12/11
HINASX Appendix 3B - Options Exercise
28/12/11
HINOption Exercise - ASX Appendix 3B
15/12/11
HINChange of Director's Interest Notice
15/12/11
HINHeartWare to Present at Oppenheimer Healthcare Conference
12/12/11
HINChange of Director's Interest Notice
06/12/11
HINAppendix 3B - Options Exercise
06/12/11
HINAmended Change of Director's Interest Notice
05/12/11
HINASX Appendix 3B - Options Exercise
25/11/11
HINHeartWare to Present at Piper Jaffray Health Care Conference
24/11/11
HINChange of Director's Interest Notice
18/11/11
HINASX Appendix 3B - Options Exercise
14/11/11
HINHeartWare to Present at Lazard Capital Markets Healthcare Co
11/11/11
HINThird Quarter 2011 Financial Results
04/11/11PRICE SENSITIVE
HINHeartWare Announces Third Quarter Revenues of US$21.3 M
28/10/11PRICE SENSITIVE
HINHeartWare Announces Planned Departure of CFO
28/10/11PRICE SENSITIVE
HINNotice of Third Quarter Financial Results Call
24/10/11
HINGrant of Incentive Equity - ASX Appendix 3B
20/10/11
HINChange of Director's Interest Notice
10/10/11
HINPresentation of Clinical Update for BTT and CAP at EACTS
03/10/11
HINHeartWare Announces Updated Clinical Data Presented at EACTS
03/10/11PRICE SENSITIVE
HINHeartWare to Present Clinical Update at 25th EACTS in Lisbon
29/09/11
HINASX Appendix 3B - Options Exercise and Vesting
22/09/11
HINChange of Director's Interest Notice
21/09/11
refresh Created with Sketch. REFRESH
 

Top Stories

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.